维普中文期刊产品整合服务
18篇 您的检索式:作者名="RUFFION"
    题名 作者 年代 出处 被引量
1Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia显示文摘Bozec A Ruffion A Decaussin M 2005J Clin Endocrinol Metab2005,90,1:1
2p53 immunodetection of liquid-based processed uri,lary samples helps to identify bladder turnouts with a higher risk of progression 显示文摘Piaton E Faynel J Ruffion A 2005Br J Cancer2005,93,2:1
3Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder显示文摘Ruffion Alain Castro-diaz David Patel Hetal Khalaf Kristin Onyenwenyi Ahunna Globe Denise Lereun Corinne Teneishvili Mamuka Edwards Meredith 2013Neuroepidemiology . 2013 (3-4)2013,,3:1
4Activation of Caspase-3,-6, and-9 cluring finasteride tveatment of benign prostatic hyperplasia显示文摘Bozec A Ruffion A 2005J Clin Endocrinol Metal2005,90,1:1
5Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses 显示文摘Grise P Ruffion A 2010Eur Uro12010,58,5:1
6p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression显示文摘Piaton E Fanel J Ruffion A 2005Br J Cancer2005,93,2:1
7p53 immunode- tection of liquid-based processed urinary samples helps to indentify bladder tumors with a higher risk of pro- gression显示文摘Piston E Faynel J Ruffion A 2005Br J Cancer2005,93,2:1
8p53 immunodetection of liquid-based processed urinary samples helps to identify bladder turnouts with a higher risk of progression显示文摘Piaton E Fa~nel J Ruffion A 2005Br J Cancer2005,93,2:1
9Efficacy and tolerability of botuli- num toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses 显示文摘Grise P Ruffion A Denys P 2010Eur Urol2010,58,5:1
10Activation of caspases-3, -6 ,and-9 during finasteride treatment of benign prostatic hyperplasia 显示文摘Bozec A Ruffion A Decaussin M 2005J Clin Endocrinol Metab2005,90,1:1
11Renal failure and neurogenic bladder显示文摘Ruffion A Villar E Denys P 2007Prog Urol2007,17,3:1
12Activation of caspases- 3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia显示文摘Bozec A Ruffion A Decaussin M 2005J Clin Endocrinol Metab2005,90,1:1
13Systematic review of the epidemology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder 显示文摘RUFFION A CASTRO-DIAZ D PATEL H 2013Neuroepidemiology2013,41,34:1
14Prostate Hypofractionated Radiotherapy with Injection of Hyaluronic Acid. Acute Toxicities in the RPAH1 Phase II Study显示文摘Olivier Chapet Evelyne Decullier Sylvie Bin Antoine Faix Alain Ruffion Patrice Jalade Pascal Fenoglietto Corina Udrescu Ciprian Enachescu David Azria 2014International Journal of Radiation Oncology, Biology, Physics2014,,:1
15RENAL ARTERIOVENOUS MALFORMATION REQUIRING SURGERY IN RENDU-OSLER-WEBER DISEASE (HEREDITARY HEMORRHAGIC TELANGIECTASIA)显示文摘MOHAMED ZIANI CHRISTOPHE VALIGNAT JEAN-GABRIEL LOPEZ ALAIN RUFFION HENRI PLAUCHU PAUL PERRIN 2000The Journal of Urology2000,,4:1
16Preservation of' prostate during rad- ical cystectomy : evaluation of prevalence of prostate cancer associated with bladder cancer 显示文摘Ruffion A Mane1 A Massoud W 2005Urology2005,65,4:1
17Can Sacral Neuromodulation Improve Minor Incontinence Symptoms in Doubly Incontinent Patients Successfully Treated for Major Incontinence Symptoms?显示文摘Romain Caremel Henri Damon Alain Ruffion Emmanuel Chartier-Kastler Guillaume Gourcerol Francis Michot Jean-Fran?ois Menard Philippe Grise Anne-Marie Leroi 2012Urology2012,,1:1
18Preservation of prostate dur- ing radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer 显示文摘Ruffion A Manel A Massoud W 2005Urology2005,65,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费